Completed PHASE3 INTERVENTIONAL 1-arm NCT02696096

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Sponsor: Butler Hospital

Updated 9 times since 2017 Last updated: Jul 19, 2022 Started: Aug 31, 2016 Primary completion: Feb 29, 2020 Completion: Feb 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02696096, this PHASE3 trial focuses on Opioid Addiction and remains completed. Sponsored by Butler Hospital, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Sep 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Sep 2022 [monthly]

Completed PHASE3
Jun 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 4 earlier versions

Jun 2019 — Jun 2020 [monthly]

Recruiting PHASE3
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE3
Apr 2017 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Apr 2017 [monthly]

Not Yet Recruiting PHASE3

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Butler Hospital

Data source: Butler Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Providence, United States